Patents by Inventor Shannon LAYLAND

Shannon LAYLAND has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Means and Methods to Treat Diabetes
    Publication number: 20220016219
    Abstract: The present application relates to a pharmaceutical composition for use in a method of treating diabetes in a human or animal subject in need thereof, to transplantation devices comprising the pharmaceutical composition of the present invention and to methods of treating diabetes using the pharmaceutical composition and transplantation device of the present invention.
    Type: Application
    Filed: July 28, 2021
    Publication date: January 20, 2022
    Applicant: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
    Inventors: Shannon Layland, Katja Schenke-Layland, Garry Duffy, Svenja Hinderer, Aline Zbinden
  • GLYCOSYLATED PROTEIN OF AN EXTRA-CELLULAR MATRIX FOR USE IN A METHOD OF TREATING AN ISCHEMIC HEART OF A HUMAN OR ANIMAL SUBJECT IN NEED THEREOF
    Publication number: 20160158314
    Abstract: The present invention relates to a glycosylated protein of an extracellular matrix, preferably of a mammalian extra-cellular matrix for use in a method of treating an ischemic heart of a human or animal subject in need thereof, a pharmaceutical composition comprising said glycosylated protein and a method for the in vitro production of differentiated cardiomyocytes.
    Type: Application
    Filed: July 31, 2014
    Publication date: June 9, 2016
    Applicant: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Shannon LAYLAND, Katja SHENKE-LAYLAND, Monika HOLEITER